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Flap fixation reduces seroma in patients
undergoing mastectomy: a significant
implication for clinical practice
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Abstract
Background: Seroma formation is a common complication following mastectomy for invasive breast cancer.
Mastectomy flap fixation is achieved by reducing dead space volume using interrupted subcutaneous sutures.
Methods: All patients undergoing mastectomy due to invasive breast cancer or ductal carcinoma in situ (DCIS)
were eligible for inclusion. From May 2012 to March 2013, all patients undergoing mastectomy in two hospitals
were treated using flap fixation. The skin flaps were sutured on to the pectoral muscle using polyfilament
absorbable sutures. The data was retrospectively analysed and compared to a historical control group that was not
treated using flap fixation (May 2011 to March 2012).
Results: One hundred and eighty patients were included: 92 in the flap fixation group (FF) and 88 in the historical
control group (HC). A total of 33/92 (35.9 %) patients developed seroma in the group that underwent flap fixation;
52/88 (59.1 %) patients developed seroma in the HC group (p = 0.002). Seroma aspiration was performed in 14/92
(15.2 %) patients in the FF group as opposed to 38/88 (43.2 %) patients in the HC group (p < 0.001).
Conclusions: Flap fixation is an effective surgical technique in reducing dead space and therefore seroma
formation and seroma aspirations in patients undergoing mastectomy for invasive breast cancer or DCIS.
Background
Seroma formation, a collection of serous fluid that con-
tains blood plasma and/or lymph fluid, is a common side
effect after mastectomy. It has an incidence of 3 to 85 %
[1], and some surgeons regard seroma formation as an
inherent part of breast cancer surgery. Seroma formation
and its sequelae form the mainstay of complications in
breast cancer surgery, varying from delayed wound healing,
infection, skin flap necrosis and patient discomfort [2].
Patient discomfort seems mainly to be caused by frequent
seroma aspirations and repeated visits to the outpatient
clinic to deal with seroma and its sequelae.
Seroma formation continues to be a problem for pa-
tients undergoing surgery of the breast and/or axilla for
invasive breast cancer. Pathogenesis of seroma is not yet
fully understood. Several factors are held responsible for
seroma formation. In a retrospective cross-sectional study
by Hashemi et al., patients undergoing modified radical
mastectomy (MRM) were shown to be 2.5 times more
likely to develop seroma [3]. Gonzalez et al. analysed
patients undergoing wide local excision and MRM for in-
vasive breast cancer and concluded that the type of oper-
ation performed was the only predictor of seroma
formation [4], whereas age of the patient, the presence
and number of positive axillary lymph nodes, the total
number of axillary lymph nodes removed, tumour size,
weight of the patient and the use of neoadjuvant chemo-
therapy were not. The use of electrocautery has been
demonstrated to increase seroma formation following
mastectomy [5]; however, no other surgical devices (laser
scalpel, argon diathermy and ultrasonic scalpel) or sub-
stances have proven to be superior in seroma reduction [6].
Seroma formation after axillary dissection for breast can-
cer cannot be avoided, but it can possibly be minimised by
mechanical closure of the dead space [7]. Prospective trials
have demonstrated that flap anchoring after mastectomy,
and therefore dead space reduction, could be very beneficial
[8]. The trial performed by Almond et al. on flap fixation
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compared to closed suction drainage showed no difference
in seroma rates, but patients without drains were dis-
charged earlier [8]. In the trial performed by Sakkary, the
amount of fluid drained was significantly less in the flap fix-
ation group [9]. In these studies, however, patient discom-
fort in terms of seroma aspiration and repeated hospital
visits were not assessed. The most recently published retro-
spective study on quilting of the skin flaps after mastectomy
and/or axillary lymph node dissection showed promising
results [10]. In this study, quilting of the skin flaps led to
less seroma formation, fewer seroma aspirations and fewer
surgical site infections (SSIs).
A systematic review performed by Kyeong-Tae Lee et al.
[11] in seroma formation after latissimus dorsi muscle
harvesting suggests that dead space formation is one of
the leading mechanisms in seroma formation. Prolonged
leakage into the dead space by disrupted lymphatics and
blood vessels most likely contributes to seroma formation
[11]. The pathogenesis of seroma formation and its con-
tributing mechanisms are not yet fully understood and re-
quire further investigation.
We hypothesise that obliteration of the dead space
using sutured flap fixation following mastectomy will
significantly reduce seroma formation, resulting in fewer
seroma aspirations and outpatient visits. The aim of this
retrospective observational cohort study is to demon-
strate that patients undergoing mastectomy with flap fix-
ation in combination with low suction drainage undergo
fewer seroma aspirations.
Methods
This retrospective study was conducted in the breast units
of two large hospitals in the Netherlands (Atrium Medical
Centre, Heerlen and Orbis Medical Centre, Sittard). The
hospitals’ joint medical ethical committee granted ap-
proval (13-N-77), and informed consent was waived.
All patients undergoing mastectomy, mastectomy and
sentinel node procedure or modified radical mastectomy
for invasive breast cancer or ductal carcinoma in situ
(DCIS) older than 18 years of age were eligible for inclu-
sion. Patients undergoing direct breast reconstruction
were excluded from this study. All patients received 2 g
of cefazolin prophylaxis preoperatively. Low vacuum
drains were inserted in all patients before wound clos-
ure. Drains were removed if fluid production was less
than 50 mL/24 h. After 7 days, all drains were removed,
irrespective of drain output. Five dedicated breast cancer
surgeons performed the procedures. Patients were ana-
lysed in two separate 10-month intervals in which the
method of wound closure differed.
Historical control group (HC)
From May 2011 to March 2012, patients underwent
conventional wound closure using subcutaneous and
intradermal absorbable sutures. Closed suction drainage
was applied to all patients.
Flap fixation group (FF)
From May 2012 to March 2013, all patients underwent
wound closure using flap fixation. After the mastectomy,
the skin flaps were sutured on to the pectoral muscle
with polyfilament absorbable sutures (Vicryl 3.0). Su-
tures were placed at 3-cm intervals in two or three rows,
depending on the extent of the skin flaps (Fig. 1). This
procedure was done as described by Almond et al. in
2010 [8], without closing the axillary dead space with su-
tures. Care was taken to prevent dimpling of the skin.
Data was extracted from electronic patient files by one
of the co-authors. Operation reports and physicians’ and
specialised nurse practioners’ outpatient clinic notes
were analysed. Patient demographics (age, comorbidity,
use of anticoagulant drugs, smoking, tumour stage, type
of operation, blood loss and comorbidity) were noted.
The Charlston comorbidity index was used to assess co-
morbidity [12]. Infection was defined as any wound ap-
pearance that required antibiotic treatment or surgery to
evacuate infected seroma or abscess. Seroma was defined
as a fluid collection as evidenced via palpation or clear
serous fluid that was aspirated. Seroma aspirations were
counted as registered in the patients’ charts.
Statistics
Continuous variables are presented as means with stand-
ard deviations or as medians with first and third quartiles
as appropriate; categorical variables are presented as per-
centages. Continuous variables were compared between
study groups with Student t tests or Mann-Whitney U
tests as appropriate. Categorical variables were compared
between study groups with chi-squared tests or Fisher
exact tests as appropriate. The risk of complications ac-
cording to study group was estimated using simple logistic
Fig. 1 Schematic depiction of points of flap fixation
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regression. Potential confounding by relevant baseline
characteristics was corrected for using multiple logistic re-
gressions. The clinically relevant interaction between
study group and operation type was assessed with the sig-
nificance of the change in −2 log likelihood after inclusion
of the interaction term in the logistic regression models.
In case of significant interaction, simple effects were re-
ported by stratified cross-tables. p < 0.05 was considered
evidence of statistical significance.
Results
In total, 835 breast cancer surgeries were performed in
both 10-month intervals.
One hundred and eighty patients were included: 92 in
the FF group and 88 in the HC group. Patient demo-
graphics (age, comorbidity, use of anticoagulant drugs,
smoking, tumour stage, type of operation, blood loss and
comorbidity) were not significantly different (Table 1).
In the group that underwent flap fixation, 33/92
(35.9 %) patients developed a seroma, compared to 52/
88 (59.1 %) patients in the HC group (p = 0.002). Seroma
aspiration was performed in 14/92 (15.2 %) patients in
the FF group as opposed to 38/88 (43.2 %) patients in
the historical control group (p < 0.001). The number of
seroma aspirations per patient that underwent seroma
aspiration was also significantly reduced in the group
undergoing flap fixation (p < 0.001). There was no sig-
nificant difference in patients developing SSIs (12.0 % in
the FF group and 17.0 % in the HC group, p = 0.33).
These results are shown in Table 2.
Multivariate analysis revealed a trend in smokers to
develop seroma (p = 0.05), as shown in Table 3.
When analysing the effect of flap fixation on seroma
formation stratified by operation type, no effect was seen
in the group undergoing mastectomy (p = 0.16 for ser-
oma formation and p = 0.35 for seroma aspiration). In
the group undergoing mastectomy and a sentinel node
procedure, seroma formation was significantly reduced
(FF 25.0 %, HC 61.9 %, p < 0.001) as well as seroma aspi-
rations (FF 13.5 %, HC 45.2 %, p = 0.001). In patients
undergoing MRM, there were no differences in seroma
formation (55.9 % in the FF group and 56.2 % in the HC
group); however, there was a statistical difference in the
seroma aspirations in this group. Fewer patients required
seroma aspiration in the group undergoing flap fixation
(flap fixation 17.6 %, historical control 40.6 %, p = 0.04).
These results are shown in Table 4.
Discussion
This study demonstrates that reduction of the dead space
after mastectomy using flap fixation reduces seroma for-
mation and seroma aspirations. For many decades, breast
surgeons have used closed suction drainage to reduce
dead space. However, seroma formation and its sequelae
continued to cause postoperative problems in these pa-
tients, proving that wound drainage is insufficient in com-
bating seroma. Flap fixation combined with low suction
drainage significantly reduces seroma formation and the
need for seroma aspiration after mastectomy.
The key to reducing seroma formation seems to partly
lie in the obliteration of dead space. However, the tech-
niques used to achieve this goal are subject of much
controversy and debate [6]. In a randomised controlled
study, it was difficult to elucidate whether reducing the
dead space or ligation of lymphatics or a combination of
both were responsible for reduction of seroma formation
Table 1 Patient characteristics and surgical aspects
Flap fixation Historical control p
N = 92 N = 88
Age (years) 67 (±13) 71 (±11) 0.07
Comorbidity 2.8 (±1.4) 3.0 (±1.1) 0.45
Anticoagulant drugs (yes) 25.0 % 34.1 % 0.18
Smoking (yes) 22.8 % 23.9 % 0.82
Tumour stage 0.34
T1-2N0 44.6 % 50.0 %
T1-2N+ 25.0 % 19.3 %
T3 14.1 % 9.1 %
T4 3.3 % 9.1 %
DCIS 13.0 % 12.5 %
Operation 0.12
MRM 37.0 % 36.4 %
Mastectomy 6.5 % 15.9 %
Mastectomy + sentinel node 56.5 % 47.7 %
Blood loss 0.11
0 mL 48.9 % 36.4 %
0–50 mL 18.5 % 17.0 %
50–100 mL 17.4 % 13.6 %
100–150 mL 3.3 % 2.3 %
>150 mL 11.9 % 30.7 %
Data are presented as means with standard deviations or as percentages.
All patients were evaluated
Table 2 Postoperative complications
Flap fixation Historical control p
N = 92 N = 88
Any complication 39.1 % 63.6 % 0.001
Seroma 35.9 % 59.1 % 0.002
Seroma requiring aspiration 15.2 % 43.2 % <0.001
Number of aspirations 0 (0–0) 0 (0–1) <0.001
Hematoma 5.4 % 1.1 % 0.21
SSI 12.0 % 17.0 % 0.33
Pneumothorax 0.0 % 1.1 % 0.49
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[13]. The extent of the dissection plane seems to be an im-
portant factor in seroma formation, and therefore, obliter-
ation of dead space in patients undergoing mastectomy or
modified radical mastectomy seems to be pivotal. Pressure
garments or compression bandages are not effective in
combating seroma; however, quilting of the skin flaps or
skin flap fixation seems to be much more effective [10, 14].
When analysing the effect of flap fixation on seroma
formation stratified by operation type, no significant ef-
fect was seen in seroma formation or seroma aspiration
in the group undergoing mastectomy alone (seroma for-
mation p = 0.16, seroma aspiration p = 0.35). The low
number of patients in this subgroup could explain the
non-significance, as a clear trend is visible. If this group
had been larger (n = 20), the difference possibly might
have been statistically significant.
In the group undergoing MRM, flap fixation was less
effective on seroma formation, although there were
fewer seroma aspirations. In this group of patients, ser-
oma formation could be more pronounced due to the
axillary lymph node dissection, and therefore, there
might be a relative under treatment of the axilla when
evaluating seroma prophylaxis. Several studies have been
performed to assess the effect of sealing devices on ser-
oma formation in axillary dissection [7]. The use of the
harmonic scalpel has been shown to reduce the magni-
tude of seromas in the axilla [15]. In another prospective
randomised controlled trial performed by Cortadellas
et al., the use of an electrothermal bipolar vessel sealing
system (LigaSure) in axillary dissection was assessed.
The mean number of postsurgical seroma aspirations
and the amount of seroma fluid drained were lower in
the LigaSure group; however, they were not statistically
significant [16].
No significant differences in SSIs were seen in this
study. This could be due to the fact that all patients were
treated with prophylactic antibiotics and strict operating
room discipline was in place. This entailed limiting door
openings in theatre and thus limiting movements of the-
atre staff during procedures. A difference of 5 % in infec-
tion rates between both groups was too small to achieve
statistical significance. The reported rates of SSIs after
breast operations range dramatically from 0.8 to 26 % in
the literature. One possible factor accounting for such
wide-ranging SSI rates is the use of different definitions
of SSIs [17].
Cosmesis and shoulder function on the ipsilateral side
were not evaluated in this study. One patient in the flap fix-
ation group suffered from a diminished shoulder function
postoperatively. It was unclear whether there was full range
of motion preoperatively. Another patient in the flap fix-
ation group appeared to develop skin dimpling on the chest
wall 6 months after surgery. No studies to date have been
published regarding cosmesis, shoulder function and pa-
tient satisfaction with long-term follow up after flap fix-
ation. This should be addressed in a prospective trial.
The main limitations of this study are related to the
retrospective nature. Being a retrospective study, indica-
tions for seroma aspiration had not been defined
Table 3 Multiple logistic regression analysis
Seroma Seroma requiring aspiration
Odds ratio (95 % CI) p Odds ratio (95 % CI) p
Flap fixation (yes) 0.41 (0.22–0.79) 0.008 0.29 (0.14–0.60) 0.001
Age (years) 1.02 (0.99–1.05) 0.33 1.02 (0.99–1.06) 0.24
Operation 0.20 0.96
Mastectomy (reference) – –
Mastectomy and sentinel node 1.13 (0.39–3.34) 0.96 (0.31–2.92)
Modified radical mastectomy 2.09 (0.66–6.64) 1.07 (0.33–3.55)
Comorbidity 1.06 (0.77–1.47) 0.72 1.25 (0.89–1.76) 0.20
Anticoagulant drugs (yes) 0.85 (0.37–1.96) 0.71 0.79 (0.32–1.96) 0.61
Smoking (yes) 2.16 (0.99–4.70) 0.05 0.71 (0.30–1.69) 0.44






Mastectomy 8/14 (57.1 %) 1/6 (16.7 %) 0.16
Mastectomy and sentinel
node
26/42 (61.9 %) 13/52 (25.0 %) <0.001
Modified radical mastectomy 18/32 (56.2 %) 19/34 (55.9 %) 0.98




Mastectomy 6/14 (42.9 %) 1/6 (16.7 %) 0.35
Mastectomy and sentinel
node
19/42 (45.2 %) 7/52 (13.5 %) 0.001
Modified radical mastectomy 13/32 (40.6 %) 6/34 (17.6 %) 0.04
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beforehand. This might be a potential confounder in this
study. However, this is the first study to evaluate seroma as-
piration in mastectomy patients treated with flap fixation
and low suction wound drainage. Assessing the presence of
seroma is difficult due to the subjective nature of this pro-
cedure. How does one objectively measure the presence of
seroma? Maybe the only true measure for seroma is seroma
aspiration. There were no major policy changes in the treat-
ment of seroma in both time intervals, but bias is of course
possible. There does seem to be an increasing surgical ten-
dency towards watchful waiting when treating postopera-
tive wound seroma.
Seroma aspiration is clinically relevant to our group of
patients, and it is an important cause of patient discom-
fort [2]. Seroma leads to prolonged hospital stay, a
higher rate of infections and therefore delayed adminis-
tration of adjuvant treatment [18]. Patients undergo
more frequent outpatient clinic visits, a higher rate of
surgical reinterventions and patients may have a worse
cosmetic outcome [10]. Finally, the cost of medical care
is higher in the group of patients suffering from seroma
and its sequelae [19].
The strength of this study lies in the proven efficacy of
flap fixation after mastectomy in 180 patients in two
large teaching hospitals. The most important outcome is
diminished seroma aspirations in the group having
undergone flap fixation when compared to patients with
only low suction drainage postoperatively. This in itself
should lead to a further reduction of patient discomfort.
Conclusions
Flap fixation is a surgical technique that reduces the
dead space in patients undergoing mastectomy for inva-
sive breast cancer or DCIS. It appears to reduce the oc-
currence of seroma and the need for seroma aspirations.
A prospective trial can further evaluate the effect of flap
fixation, including long-term outcome measures such as
cosmesis, shoulder function and patient satisfaction.
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